JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 7 April 2006. doi:10.1136/jcp.2005.034280
Journal of Clinical Pathology 2006;59:753-758
Copyright © 2006 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jcp.2005.034280v1
jcp.2005.034280v2
59/7/753    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reynolds, T M
Right arrow Articles by Van Nueten, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reynolds, T M
Right arrow Articles by Van Nueten, J

ORIGINAL ARTICLE

Weight correction of MoM values: which method?

T M Reynolds1, G Vranken2, J Van Nueten2

1 Queens Hospital, Burton on Trent, Staffordshire, UK; Division of Clinical Sciences, Wolverhampton University, Wolverhampton, UK
2 Analis NV, Gent, Belgium

Correspondence to:
T M Reynolds
Clinical Chemistry Department, Queen’s Hospital, Belvedere Road, Burton on Trent, Staffordshire DE13 0RB, UK; tim.reynolds{at}burtonh-tr.wmids.nhs.uk Background: Adjusting maternal serum markers for maternal weight is considered to be a standard practice when screening for pregnancies associated with Down’s syndrome. The choice of model for taking maternal weight into account is, however, rarely explicitly evaluated.

Method: The relationship between the maternal serum markers {alpha}fetoprotein (AFP), human chorionic gonadotropin (HCG) and unconjugated oestriol (uE3), determined with the Beckman Coulter access reagents and maternal weight was investigated in a cohort of 752 Belgian women being screened for pregnancy associated with Down’s syndrome. Two different models (the log–linear equation and the linear–reciprocal equation) were used to determine the relationship between the serum markers and maternal weight.

Results: A significant relationship between log10 multiples of median (MoM) values and weight (kg) was obtained for all markers, and the log–linear model had higher coefficients of determination (r2) when compared with the linear–reciprocal model. Weight correction with either method achieved the optimum effect that the correction factor for a woman with a population median weight of 65.5 kg was not significantly different from 1. Simulated weight-corrected MoM values with the two approaches were compared and variation was estimated. The mean difference between the weight-corrected MoM values calculated by the two methods was 7.8% (SD 4.3%) for AFP, 14.0% (4.4%) for HCG and 5.9% (3.2%) for uE3. This resulted in a difference in risk estimate of 1.66–5.34% for Down’s syndrome owing to weight correction algorithm differences in women of median weight.

Conclusion: The log–linear weight correction approach was shown to be marginally more effective by a goodness-of-fit analysis. Differences in weight-corrected MoM values estimated with the two approaches are highly significant (p<0.0001, Wilcoxon’s paired sample test), but the effect on risk calculation was not significant. It was observed that the changes in risk became significant the more the MoM correction factors deviated from 1.


Abbreviations: AFP, {alpha}fetoprotein; HCG, human chorionic gonadotropin; MoM, multiples of median; uE3, unconjugated oestriol




This article has been cited by other articles:


Home page
Obstet GynecolHome page
J.-P. Le Meaux, V. Tsatsaris, T. Schmitz, Y. Fulla, O. Launay, F. Goffinet, and E. Azria
Maternal Biochemical Serum Screening for Down Syndrome in Pregnancy With Human Immunodeficiency Virus Infection
Obstet. Gynecol., August 1, 2008; 112(2): 223 - 230.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.